Intuitive Surgical Inc. (ISRG)
ISRG · Health Care · 
United States
Intuitive Surgical Inc. (ISRG) is a US company in the Health Care sector. The stock has its largest weight in XUHL (MSCI USA Health Care), at 2.37%. Anyone who holds an ETF containing Intuitive Surgical also has an indirect stake in the company.
Data and Charts: Intuitive Surgical
Key Data for Intuitive Surgical
Intuitive Surgical Stock Price Chart
The Intuitive Surgical chart shows daily closing prices and is set to the current year by default. The stock is down 23.7% year to date and down 18.5% over twelve months. The last recorded close on October 30, 2026, was $432.01, at 38% of the 52-week range.
Price series from our database since Aug 12, 2024, 558 daily values.
Intuitive Surgical Stock Performance
| Year to date | -23.7% | 1 year | -18.5% |
|---|---|---|---|
| 1 month | +6.2% | 3 months | +22.3% |
| Calendar year 2025 | +8.5% |
Measured in euros, Intuitive Surgical is down 19.8% year to date and down 15.7% over twelve months. The difference from the dollar figures above comes from the exchange rate alone. Each daily price is converted at the ECB euro reference rate for that day.
Alysly Data Analysis: Intuitive Surgical
What ETF Is Intuitive Surgical In?
Intuitive Surgical has above-average ETF coverage and is held by 23 of the 104 ETFs we track, which together follow 10 indices. That puts the stock in more ETFs than 87.8% of the 4,341 stocks we track.
| ETF | Index | Weight | per €1,000 in the ETF |
|---|---|---|---|
| XUHL / XUHC | MSCI USA Health Care | 2.37% | €23.69 |
| SPFS | MSCI World Health Care | 1.76% | €17.55 |
| XDWH | MSCI World Health Care | 1.75% | €17.52 |
| EXXT | Nasdaq 100 | 0.69% | €6.90 |
| XNAS / XNA1 | Nasdaq 100 | 0.69% | €6.87 |
| XDEW | S&P 500 Equal Weight | 0.25% | €2.47 |
| SPYL / SPY5 | S&P 500 | 0.24% | €2.40 |
| SXR8 | S&P 500 | 0.24% | €2.40 |
| XD9U / XD9D | MSCI USA | 0.24% | €2.38 |
| XDWD / XDWL | MSCI World | 0.17% | €1.74 |
| SWWD | MSCI World | 0.17% | €1.73 |
| SPPW | MSCI World | 0.17% | €1.73 |
| EUNL | MSCI World | 0.17% | €1.70 |
| WIMI | MSCI World IMI | 0.16% | €1.56 |
| SPYY | MSCI ACWI | 0.16% | €1.56 |
| IUSQ | MSCI ACWI | 0.15% | €1.50 |
| SPYI / SPSA | MSCI ACWI IMI | 0.13% | €1.27 |
The last column shows how much of €1,000 in one of these funds goes to Intuitive Surgical, based on each fund's latest holdings list.
US-listed ETFs holding Intuitive Surgical (weight per latest SEC filing): QQQ 0.61%, QQQM 0.59%, VUG 0.40%, ONEQ 0.29%, IVV 0.22%, SPY 0.22%, VOO 0.22%, VTI 0.19%. These funds are registered in the US; retail investors in the EU usually cannot buy them.
Intuitive Surgical Weight in iShares Core MSCI World (EUNL) Since 2019
In iShares Core MSCI World (EUNL), Intuitive Surgical had a weight of 0.15% on Sep 30, 2019 and 0.17% on Oct 29, 2026. The fund tracks the MSCI World. Its share peaked at 0.26% on Dec 31, 2024. The weight rises and falls with the stock's price performance relative to the other index members. It can also change when the index provider adjusts the index composition.
What's Inside Your ETF Portfolio and the ETF overlap check show how much Intuitive Surgical overlaps with the rest of a portfolio.
Which Tracked Investors Hold Intuitive Surgical?
Intuitive Surgical is not among the largest purchases in the quarter ending Jun 30, 2026. The list is led by GOOGL, DAL and NEBIUS GROUP N.V. The only manager we track that holds Intuitive Surgical increased its position.
| Investor | Shares | Value | Quarter |
|---|---|---|---|
| Bridgewater Associates | 19,324 | $8M | increased by 2,030 |
As of Jun 30, 2026. Based on quarterly filings with the US securities regulator, submitted up to 45 days after the reference date. The change counts shares, not price gains.
What Intuitive Surgical Executives and Directors Traded Recently
| Date | Person | Type | Shares | Price |
|---|---|---|---|---|
| Oct 28, 2026 | Brosius Mark Officer, EVP & Chief Mfg and Supply Cha | Sell (plan) | 61 | $441.60 |
| Oct 27, 2026 | Brosius Mark Officer, EVP & Chief Mfg and Supply Cha | Sell (plan) | 61 | $451.63 |
| Oct 26, 2026 | Brosius Mark Officer, EVP & Chief Mfg and Supply Cha | Sell (plan) | 61 | $451.75 |
| Oct 23, 2026 | Widman Fredrik Officer, VP Corporate Controller | Sell (plan) | 4,047 | $453.21 |
| Oct 23, 2026 | GUTHART GARY S Director | Sell (plan) | 20,095 | $451.61 |
| Oct 23, 2026 | BARRATT CRAIG H Director | Sell (plan) | 1,150 | $443.80 |
| Oct 23, 2026 | WADORS PATRICIA L Officer, SVP Chief Human Resources Offi | Sell (plan) | 1,078 | $443.80 |
The table shows open-market purchases and sales reported over the past 90 days. Directors, officers and shareholders owning more than ten percent must report such transactions within two trading days. Awards and option exercises are excluded.
“Plan” means the transaction follows a schedule set up in advance under Rule 10b5-1. Sales consistently outnumber purchases in these filings because a large part of executive pay is granted in shares. For comparison: over the period covered, executives and directors reported sales at 271 of 350 tracked companies and purchases at 32.
Stocks With ETF Exposure Similar to Intuitive Surgical
| Stock | Shared ETFs | r | 1 year | Annualized volatility | Net margin | Revenue growth |
|---|---|---|---|---|---|---|
| Intuitive Surgical | – | – | -18.5% | 34.2% | 28.4% | +20.5% |
 Regeneron Pharmaceuticals | 23 | – | +41.9% | 36.5% | 31.4% | +1.0% |
 DexCom | 23 | – | +20.7% | 40.8% | 17.9% | +15.6% |
 IDEXX Laboratories | 23 | +0.53 | -12.3% | 36.6% | 24.6% | +10.4% |
 GE Healthcare Technologies | 23 | – | +2.1% | 34.1% | 10.1% | +4.8% |
 Amgen | 23 | – | +59.6% | 27.7% | 21.0% | +10.0% |
 Vertex Pharmaceuticals Incorporated | 23 | – | +33.1% | 31.8% | 32.9% | +8.9% |
 Boston Scientific Corporation | 20 | +0.51 | -58.3% | 30.9% | 14.4% | +19.9% |
 Danaher Corporation | 20 | – | +8.0% | 30.5% | 14.7% | +2.9% |
These stocks reach a portfolio through largely the same funds as Intuitive Surgical. “Shared ETFs” counts the funds that hold both.
Return and volatility are calculated from our daily closing prices in US dollars. Margin and growth come from each company's latest SEC annual filing. Because fiscal years do not end on the same date for every company, the underlying periods are not fully identical.
Fundamental Analysis: Intuitive Surgical
Intuitive Surgical Key Financials
Figures come from the SEC annual filing for the latest reported fiscal year (period end Dec 31, 2025).
| Fiscal year | Revenue | Net income | Margin |
|---|---|---|---|
| FY ended Dec 2023 | 7.1 | 1.8 | 25.2% |
| FY ended Dec 2024 | 8.4 | 2.3 | 27.8% |
| FY ended Dec 2025 | 10.1 | 2.9 | 28.4% |
Technical Analysis: Intuitive Surgical
Intuitive Surgical Risk Metrics
The close on Oct 30, 2026, was 29.2% below the highest close since Aug 12, 2024. That high was reached on Jan 22, 2025. When the S&P 500 rose or fell 1%, Intuitive Surgical moved 0.89% on average in the same direction (past 252 trading days). The correlation of 0.33, however, shows only a moderate link to the broad market. Accordingly, moves in the S&P 500 explain only a small part of the daily price moves of Intuitive Surgical.
What Intuitive Surgical Correlates With
| Instrument | r | −1 … +1 |
|---|---|---|
| Stryker Corporation | +0.61 | |
| IDEXX Laboratories Inc. | +0.53 | |
| Zimmer Biomet Holdings Inc. | +0.53 | |
| ResMed Inc. | +0.52 | |
| Boston Scientific Corporation | +0.51 | |
| STERIS plc | +0.51 | |
| Woodside Energy Group Ltd. | -0.43 | |
| Equinor ASA | -0.38 | |
| Canadian Natural Resources Limited | -0.36 |
The strongest co-movers are listed at the top, the strongest inverse movers at the bottom. Low or negative correlations can help spread risk more broadly across a portfolio.
